Moreover, although the results uncovered that ACE2 showed the highest correlations with immunomodulators, TIICs, and immune checkpoints in BC, whether Ang-1–7 could modulate the TME in other cancers was still unknown and needed to be further explored. Here, ACE2 is linked to cancer.